Projects per year
Abstract
Experimental and clinical evidence suggests that tumor-associated macrophages (TAMs) play important roles in cancer progression. Here, we have characterized the ontogeny and function of TAM subsets in a mouse model of metastatic ovarian cancer that is representative for visceral peritoneal metastasis. We show that the omentum is a critical premetastatic niche for development of invasive disease in this model and define a unique subset of CD163+ Tim4+ resident omental macrophages responsible for metastatic spread of ovarian cancer cells. Transcriptomic analysis showed that resident CD163+ Tim4+ omental macrophages were phenotypically distinct and maintained their resident identity during tumor growth. Selective depletion of CD163+ Tim4+ macrophages in omentum using genetic and pharmacological tools prevented tumor progression and metastatic spread of disease. These studies describe a specific role for tissue-resident macrophages in the invasive progression of metastatic ovarian cancer. The molecular pathways of cross-talk between tissue-resident macrophages and disseminated cancer cells may represent new targets to prevent metastasis and disease recurrence.
Original language | English |
---|---|
Article number | e20191869 |
Journal | The Journal of Experimental Medicine |
Volume | 217 |
Issue | 4 |
ISSN | 0022-1007 |
DOIs | |
Publication status | Published - Apr 2020 |
Keywords
- Animals
- Antigens, CD/genetics
- Antigens, Differentiation, Myelomonocytic/genetics
- Disease Models, Animal
- Disease Progression
- Female
- Gene Expression Profiling
- Macrophages/metabolism
- Membrane Proteins/metabolism
- Mice
- Mice, Inbred C57BL
- Mice, Transgenic
- Omentum/metabolism
- Ovarian Neoplasms/metabolism
- Peritoneal Neoplasms/metabolism
- Phenotype
- Receptors, Cell Surface/genetics
- Transcriptome
Fingerprint
Dive into the research topics of 'Tissue-resident macrophages in omentum promote metastatic spread of ovarian cancer'. Together they form a unique fingerprint.Projects
- 1 Active
Press/Media
-
Fjern en del af immunforsvaret og brems kræften: Ny viden giver håb for bedre behandling
26/03/2020
1 item of Media coverage
Press/Media: Press / Media